Ma. Wyatt et al., SOMATOSTATIN SST(2) RECEPTOR-MEDIATED INHIBITION OF PARIETAL-CELL FUNCTION IN RAT ISOLATED GASTRIC-MUCOSA, British Journal of Pharmacology, 119(5), 1996, pp. 905-910
1 The aim of this study was to determine the location and functional c
haracteristics of the somatostatin (SRIF) receptor type(s) which media
te inhibition of acid secretion in rat isolated gastric mucosa. 2 Gast
rin (1 nM-1 mu M), dimaprit (10 mu M-300 mu M) and isobutyl methylxant
hine (IBMX, 1 mu M-100 mu M) all caused concentration-dependent increa
ses in acid output. Responses to gastrin were almost completely inhibi
ted by ranitidine (10 mu M) at a concentration which abolished the sec
retory response to dimaprit. In contrast, responses to IBMX were not c
hanged by ranitidine suggesting that IBMX acts directly on the parieta
l cell and not indirectly by releasing histamine from enterochromaffin
-like (ECL) cells. 3 SRIF-14 (1 nM-1 mu M) had no effect on basal acid
output, but inhibited acid output produced by gastrin, dimaprit and I
BMX in a concentration-dependent manner with respective EC(50) values
of 46, 54 and 167 nM. The peptidase inhibitors, amastatin (10 mu M) an
d phosphoramidon (1 mu M), had no effect on SRIF-induced inhibition of
dimaprit stimulated gastric acid secretion. 4 The inhibitory effect o
f a range of SRIF analogues on gastrin-, dimaprit- and IBMX-induced ac
id secretion was also studied. Irrespective of the secretagogue used t
o increase acid output, the rank order of potencies was similar 7=segl
itide=octreotide>SRIF-14=SRIF-28>L-362,855). The linear peptide BIM-23
056 was devoid of agonist or antagonist activity in concentrations up
to 1 mu M. 5 The sst(2) receptor selective peptides, BIM-23027, seglit
ide and octreotide were the most potent inhibitors of gastrin-, dimapr
it- and IBMX-induced acid secretion suggesting that SRIF receptors res
embling the recombinant sst, receptors are involved. Furthermore, sinc
e dimaprit and IBMX stimulate gastric acid secretion independently of
histamine release, sst, receptor-mediated inhibition must occur at the
level of the parietal cell itself.